Cytosorbents
CTSO
$0.82
Share price
1.24%
Change (1 day)
-66.71%
Change (1 year)
Categories
EPS for Cytosorbents (CTSO)
EPS in 2023 (TTM): -$0.60
According to Cytosorbents's latest financial reports the company's current EPS (TTM) is -$0.60. In 2022 the company made an earnings per share (EPS) of -$0.75 a decrease over its 2021 EPS that were of -$0.57.
EPS history for Cytosorbents from 2006 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.60 | -20% |
| 2022 | -$0.75 | 31.58% |
| 2021 | -$0.57 | 171.43% |
| 2020 | -$0.21 | -64.41% |
| 2019 | -$0.59 | 5.36% |
| 2018 | -$0.56 | 86.67% |
| 2017 | -$0.30 | -36.17% |
| 2016 | -$0.47 | 27.03% |
| 2015 | -$0.37 | -67.55% |
| 2014 | -$1.14 | 14.02% |
| 2013 | -$1.00 | 33.33% |
| 2012 | -$0.75 | -25% |
| 2011 | -$1.00 | -20% |
| 2010 | -$1.25 | -37.5% |
| 2009 | -$2.00 | -50% |
| 2008 | -$4.00 | -11.11% |
| 2007 | -$4.50 | -80.88% |
| 2006 | -$23.53 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Boston Scientific BSX | $0.82 | -236.67% | 🇺🇸 USA |
 Hologic HOLX | $1.95 | -425.00% | 🇺🇸 USA |
 Meridian Bioscience VIVO | $0.97 | -261.67% | 🇺🇸 USA |